CVS Health has launched Cordavis, a new unit to work with manufacturers on producing biosimilar drugs for the U.S. market that cost less than their branded counterparts.
Biosimilar drugs, like generic drugs, are versions of brand-name drugs that may be more affordable to patients, according to the U.S. Food and Drug Administration (FDA).
